Ceridian HCM Nears Final Chapter as Public Company
10.12.2025 - 10:43:04Ceridian HCM US15677J1088
The countdown has begun for Ceridian HCM Holding Inc., the specialist behind the Dayforce platform, as its acquisition by the private equity firm Thoma Bravo moves toward completion. With shareholder approval secured, the company's stock now trades tightly around the agreed-upon buyout price while business operations continue uninterrupted.
Following the signing of a definitive agreement on August 21, 2025, the takeover process has accelerated. Thoma Bravo's all-cash offer of $70 per share received overwhelming support from Ceridian's shareholders in a vote held on November 12, 2025. The transaction, which carries an enterprise value of approximately $12.3 billion when including debt, represents a significant premium to the company's trading price before initial media speculation about a potential sale emerged.
Market activity now reflects the high confidence in the deal's closure. On December 9, 2025, shares opened at $69.05 and fluctuated within a narrow band between $68.91 and $69.07 throughout the trading session. This minimal volatility underscores investor expectation that the acquisition will proceed as planned. Pending customary closing conditions and regulatory approvals, the parties anticipate finalizing the deal in late 2025 or early 2026, after which Ceridian's stock will be delisted from public exchanges.
Should investors sell immediately? Or is it worth buying Ceridian HCM?
Operational Continuity Amid Ownership Transition
Despite the impending shift to private ownership, Ceridian maintains its strategic focus. Company leadership continues to emphasize the critical role of workforce data and the intelligent application of artificial intelligence within its Human Capital Management platform. The firm's stated goal is to balance AI-driven efficiency with a human-centered approach to work, a core operational value that attracted Thoma Bravo's investment.
The transition period has also seen typical regulatory filings from significant stakeholders and corporate insiders. Investment manager Price T Rowe Associates Inc. reported changes to its substantial holding on December 5, 2025. Shortly before that, on December 2, 2025, insider Stephen H. Holdridge filed a statement concerning changes in his beneficial ownership of securities. Such filings are common in the lead-up to a company leaving the public markets.
All attention is now fixed on the final procedural steps needed to conclude this $12.3 billion transaction. For investors, the coming weeks will mark the end of Ceridian's tenure as a publicly traded entity.
Ad
Ceridian HCM Stock: Buy or Sell?! New Ceridian HCM Analysis from December 10 delivers the answer:
The latest Ceridian HCM figures speak for themselves: Urgent action needed for Ceridian HCM investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from December 10.
Ceridian HCM: Buy or sell? Read more here...


